https://www.selleckchem.com/pr....oducts/lanifibranor-
ation of genome editing and transgene-free selection is an efficient strategy to accelerate functional genomic research and plant breeding. Bladder cancer (BLCA) is a common malignant tumor of urinary system with high morbidity and mortality. In recent years, immunotherapy has played a significant role in the treatment of BLCA. Tumor mutation burden (TM has been reported to be a powerful biomarker for predicting tumor prognosis and efficacy of immunotherapy. Our study aimed to explore the relationship between TMB, prognos
Like
Comment
Share
